Treatment with TGF-β1 markedly upregulated FN expression on an HPMC monolayer and induced robust adhesion of gastric cancer cells which was inhibited by an antibody to β1 integrin and RGD peptide. The gene discussed is TGFB1; the disease is gastric cancer.